Fabiom Benedetti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fabiom benedetti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fabiom Benedetti Today - Breaking & Trending Today

Chutes & Ladders—Pfizer CMO Rothenberg passes reins to Stanford's Habtezion

Erin Whitney as head of global clinical operations and
Keith White as head of global market access and has also appointed brand strategy consultant
Shauna Horvath to head of global marketing. Whitney joins the team from bluebird bio, while Merck and Genentech veteran White was most recently VP, global market access and pricing at Corbus Pharmaceuticals. Horvath joined Amylyx as a consultant in 2019.
Fabio M. Benedetti, M.D., as chief strategy officer, effective Jan. 4. Should ImmunityBio’s NantKwest merger close, Benedetti is expected to assume the role of CSO at the combined company, ImmunityBio said. Benedetti joins from combination therapy specialist Apollomics, where he was chief medical officer. ....

Stanford University , United States , Kimball Hall , San Diego , United Kingdom , Culver City , Tracy Hervey , David Rubin , Fraiser Kansteiner , Wei Lin , Stanford Habtezion , Gary Yeung , Emma Guttman Yassky , Fabiom Benedetti , Edward Kerwin , Bruce Strober , David Chacko , Keith White , Erin Whitney , Greg Zante , Brian Feagan , Anthony Dyer , Cortice Biosciences , George Farmer , Gregory Cosgrove , David Mcgovern ,

BioSpace Movers & Shakers, Jan. 1

Published: Jan 01, 2021
By Alex Keown
ImmunityBio – Fabio M. Benedetti was named chief strategy officer of California-based ImmunityBio. Benedetti will oversee life-cycle management, pipeline and commercial strategy, including medical affairs. Following the completion of ImmunityBio’s
proposed merger with NantKwest, Benedetti is expected to assume the role of chief strategy officer of the combined company. Benedetti most recently served as chief medical officer for Apollomics, Inc., where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. and CMO for Taiho Oncology, Inc. Prior to Taiho, he held the positions of senior vice president of Clinical Oncology and CMO at Geron Corporation. He also held roles at Onyx Pharmaceuticals, Millennium Pharmaceuticals, Roche and Bristol-Myers Squibb. ....

New York , United States , Zidong Zhang , Kimberly Lee , Charlotte Russel , Sergei Stetsenko , Bristol Myers Squibb , Betterlife Pharma , Greg Gara , John Fahy , Fabiom Benedetti , Christina Reimer , Geron Corporation , Taiho Oncology Inc , Division Of Pulmonary , Novotech Health , Investor Relations At Raptor Pharmaceuticals , Apollomics Inc , University Of California San Francisco , Onyx Pharmaceuticals , Department Of Medicine , Taiho Pharmaceutical Company Ltd , Investor Relations At Lexicon Pharmaceuticals , China Novotech Health Holdings , Betterlife Pharma Inc , Novotech Holding ,